Benzinga | Sep 21, 2021 05:25AM EDT

Piper Sandler Initiates Coverage On aTyr Pharma with Overweight Rating, Announces Price Target of $19

Piper Sandler analyst Edward Tenthoff initiates coverage on aTyr Pharma (NASDAQ:LIFE) with a Overweight rating and announces Price Target of $19.